CeriBell (CBLL) Fundamentals 2026 — Revenue Analysis | SniperIQ

7.20 on the NASDAQ. This SniperIQ fundamentals page covers CeriBell's valuation, profitability (net margin -63.5%), revenue ($89M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is CeriBell's market cap?

CeriBell (CBLL) has a market capitalization of approximately $652M, trading at

7.20 on the NASDAQ. Market cap moves with the live share price.

What is CeriBell's P/E ratio?

CeriBell's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 4.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is CeriBell?

CeriBell runs a net profit margin of -63.5%, a gross margin of 87.7%, and an operating margin of -68.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does CeriBell generate?

CeriBell reported revenue of $89M for fiscal year 2025, with net income of -$53M and earnings per share (EPS) of -1.46. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does CeriBell pay a dividend?

CeriBell does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is CeriBell financially healthy?

CeriBell carries a debt-to-equity ratio of 0.16x and a current ratio of 10.30x, with a market beta of 0.77. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is CeriBell a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CeriBell (CBLL) the key facts are: market cap $652M, revenue $89M, 52-week range 10.85-24.33. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.